ES2065254A1 - Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. - Google Patents

Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.

Info

Publication number
ES2065254A1
ES2065254A1 ES09300117A ES9300117A ES2065254A1 ES 2065254 A1 ES2065254 A1 ES 2065254A1 ES 09300117 A ES09300117 A ES 09300117A ES 9300117 A ES9300117 A ES 9300117A ES 2065254 A1 ES2065254 A1 ES 2065254A1
Authority
ES
Spain
Prior art keywords
peptides
related viruses
canine parvovirus
vaccines against
against canine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300117A
Other languages
English (en)
Other versions
ES2065254B1 (es
Inventor
Alvarez Jose Ignacio Casal
Olmo Carmen Vela
Joannes Pieter Langeveld
Robert Hans Meloen
Kristian Dalsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES9300117A priority Critical patent/ES2065254B1/es
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Priority to DE69415462T priority patent/DE69415462T2/de
Priority to DK94905108T priority patent/DK0647655T3/da
Priority to CA002132742A priority patent/CA2132742C/en
Priority to EP94905108A priority patent/EP0647655B1/en
Priority to PCT/ES1994/000006 priority patent/WO1994017098A1/es
Priority to AT94905108T priority patent/ATE174929T1/de
Priority to US08/307,724 priority patent/US5785974A/en
Priority to NZ259882A priority patent/NZ259882A/en
Priority to AU70048/94A priority patent/AU680264B2/en
Publication of ES2065254A1 publication Critical patent/ES2065254A1/es
Application granted granted Critical
Publication of ES2065254B1 publication Critical patent/ES2065254B1/es
Priority to GR990400812T priority patent/GR3029727T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PEPTIDOS Y VACUNAS SINTETICAS CONTRA PARVOVIRUS CANINO Y OTROS VIRUS RELACIONADOS. SE DESCRIBEN PEPTIDOS SINTETICOS CAPACES DE PRODUCIR ANTICUERPOS NEUTRALIZANTES CONTRA PARVOVIRUS CANINO (CPV). ESTOS PEPTIDOS CORRESPONDEN A SITIOS ANTIGENICOS LOCALIZADOS EN EL EXTREMO AMINO TERMINAL DE LA VP2 DE CPV QUE, ACOPLADOS A PROTEINAS TRANSPORTADORAS U OTROS COMPLEJOS INMUNOGENICOS, RESULTAN UTILES PARA FORMULAR VACUNAS CONTRA CPV Y OTROS VIRUS RELACIONADOS TALES COMO EL VIRUS DE LA PANLEUCOPENIA FELINA (FPLV) Y EL VIRUS DE LA ENTERITIS DE LOS VISONES (MEV).
ES9300117A 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados. Expired - Fee Related ES2065254B1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES9300117A ES2065254B1 (es) 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
NZ259882A NZ259882A (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvoviruses
CA002132742A CA2132742C (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
EP94905108A EP0647655B1 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
PCT/ES1994/000006 WO1994017098A1 (es) 1993-01-23 1994-01-21 Peptidos y vacunas sinteticos contra parvovirus
AT94905108T ATE174929T1 (de) 1993-01-23 1994-01-21 Synthetischen peptiden und impfstoffe gegen parvovirus
DE69415462T DE69415462T2 (de) 1993-01-23 1994-01-21 Synthetischen peptiden und impfstoffe gegen parvovirus
DK94905108T DK0647655T3 (da) 1993-01-23 1994-01-21 Syntetiske peptider og vacciner mod parvovirus
AU70048/94A AU680264B2 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
US08/307,724 US5785974A (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
GR990400812T GR3029727T3 (en) 1993-01-23 1999-03-18 Synthetic peptides and vaccines against parvovirus.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9300117A ES2065254B1 (es) 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.

Publications (2)

Publication Number Publication Date
ES2065254A1 true ES2065254A1 (es) 1995-02-01
ES2065254B1 ES2065254B1 (es) 1995-07-16

Family

ID=8280539

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9300117A Expired - Fee Related ES2065254B1 (es) 1993-01-23 1993-01-23 Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.

Country Status (1)

Country Link
ES (1) ES2065254B1 (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
ES2029938A6 (es) * 1990-07-31 1992-10-01 Ercros Sa Metodo para la obtencion de peptidos y proteinas recombinantes de fusion de la subunidad vp2 de parvovirus canino cpv, y su empleo en metodos de diagnostico y en la fdormulacion de vacunas.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ES2029938A6 (es) * 1990-07-31 1992-10-01 Ercros Sa Metodo para la obtencion de peptidos y proteinas recombinantes de fusion de la subunidad vp2 de parvovirus canino cpv, y su empleo en metodos de diagnostico y en la fdormulacion de vacunas.
ES2026826A6 (es) * 1991-03-26 1992-05-01 Ercros Sa Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.

Also Published As

Publication number Publication date
ES2065254B1 (es) 1995-07-16

Similar Documents

Publication Publication Date Title
FI943591A7 (fi) Synteettinen hemofilus-influenssa yhdistelmärokote
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
RU95105991A (ru) Конъюгат, вакцина, способы усиления иммуногенности, способы иммунизации
NO329875B1 (no) Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
DE69637914D1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ATE123035T1 (de) Pre-s-gen kodierte hepatitis-b immunogene peptide, vakzine, diagnostika und synthetische lipidische bläschenträger.
DK0585943T3 (da) Opløselige ligander for CD40
CY1111831T1 (el) Παραγωγα ογκο-συναφους αντιγονου απο την οικογενεια mage και αλληλουχιες νουκλεϊνικου οξεος που κωδικοποιουν αυτα, που χρησιμοποιουνται για την παρασκευη πρωτεϊνων συντηξης και συνθεσεων για εμβολιασμο
AU3234295A (en) Influenza virus subunit conjugates
CA2132742A1 (en) Synthetic Peptides and Vaccines Against Parvovirus
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
IL109790A0 (en) Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
ATE221786T1 (de) Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
AU2363301A (en) Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes
WO2000012122A3 (de) Niedermolekulare fragmente der hyaluronsäure zur herstellung von impfstoffen
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
ES2065254A1 (es) Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
ES1027961U (es) Soporte publicitario para carritos.
Alekseeva et al. Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues.
BRPI0009746B8 (pt) molécula de veículo contendo plasmídeo pg-pviii compreendendo uma seqúência que codifica uma parte de uma glicoproteína de lissavírus contendo pelo menos o sítio iii da glicoproteína de lissavírus mas não contendo o sítio ii, e, composição imunogênica
ES2012815A6 (es) Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma, y para preparar vacunas que los contienen.
BR0016740A (pt) Antìgenos de esporozoìto de cryptosporidium

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20141120